Financials in USD. Standardized financial statements.
A compact view of how Icosavax, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Revenue? | $582,000 | $7.80M | $1.62M | $0 |
| Revenue Growth? | -92.5% | +382.8% | 0.0% | 0.0% |
| Cost of Revenue? | $1.84M | $82,000 | $17.67M | $4.16M |
| Gross Profit? | -$1.26M | $7.72M | -$16.05M | -$4.16M |
| Gross Margin? | -216.7% | +98.9% | -993.3% | 0.0% |
| Operating Expenses? | $95.06M | $65.86M | $18.71M | $5.40M |
| Operating Income? | -$95.06M | -$65.86M | -$18.71M | -$5.40M |
| EBITDA? | -$94.20M | -$64.90M | -$18.52M | -$5.40M |
| Income Before Tax | -$91.76M | -$66.97M | -$18.85M | -$5.30M |
| Income Tax Expense | -$3.30M | $1.03M | $331,000 | -$101,000 |
| Net Income? | -$88.46M | -$68.00M | -$19.18M | -$5.20M |
| EPS? | $-2.23 | $-3.78 | $-6.67 | $-0.51 |
| Diluted EPS? | $-2.23 | $-3.78 | $-6.67 | $-0.51 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality